Relationship between the Expression of VEGF, HIF-1α, E-cadherin, p53 and Stage in Papillary Thyroid Carcinoma
![]() |
Kim, Jong-Sam
(Department of Public Health, The Graduate School of Public Health and Welfare Konyang University)
Na, Baeg-Ju (Department of Preventive Medicine, College of Medicine, Konyang University) Lee, Moo-Sik (Department of Preventive Medicine, College of Medicine, Konyang University) Kim, Chul-Woung (Department of Preventive Medicine, College of Medicine, Konyang University) Jeong, Gye-Rim (Department of Public Health, The Graduate School of Konyang University) |
1 | Naito A, Iwase H, Kuzushima T, Nakamura T, Kobayashis, " Clinical significance of E-cadherin expression in thyroid neoplasm", Surg Oncol, pp.76(3):176-80, 2001. DOI |
2 | Bunone G, Vigneri P, Mariani L, Buto S, Collini P, Pilotti S, et al, "Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features", Am J Pathol, pp. 155:1967-76, 1999. DOI |
3 | Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, Semenza GL, "Temporal, spatial, and oxygen-regulated expression of HIF-1 in the lung", Am J Physiol, pp. 275:L818-26, 1998. |
4 | Semenza GL, Jiang BH, Leung SW, et al, "Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for HIF- 1", J Biol Chem, pp.271:32529-37, 1996. DOI |
5 | Haigh PI, Urbach DR, Rotstein LE "Extent of thyroidectomy is not a major determinant of survival in low-or high-risk papillary thyroid cancer", Ann Surg Oncol, pp. 12:8189, 2005. |
6 | Park HL, Kwak JY, Kang SS, Kim DY, Kang HG, Shim JY, et al. "The analysis of tumor aggressiveness according to tumor size in occult papillary thyroid carcinoma", J Korean Surg Soc, pp.73:470-75, 2007. 과학기술학회마을 |
7 | Besic N, Pilko G, Petric R, Hocevar M, Zgajnar, "J. Papillary thyroid microcarcinoma: prognostic factors and treatment", J Surg Oncol, pp. 97:221-5, 2008. DOI |
8 | Ito T, Seyama T, Mizuno T, et al, "Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland",. Cancer Res, pp. 52:1369-71, 1992. |
9 | Bilimoria KY, Bentrem DJ, Ko CY, et al. " Extent of surgery affects survival for papillary thyroid cancer", Ann Surg, pp. 246(3):375-384, 2007. DOI |
10 | Hedinger C, Williams ED, Sobin LH, "The WHO histological classification of thyroid tumors", a commentary on the second edition Cancer, pp.63:908-11, 1989.. |
11 | Dobashi Y, Sakamoto A, Sugimora H, et al, "Overexpression of p53 as a posiible prognostic factor in human thyroid carcinoma", Am J Surg Pathol, pp. 17:375-81, 1993. DOI |
12 | Folkman J, Shing Y, "Angiogenesis" J Biol Chem, pp. 267:10931-4, 1992. |
13 | Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P, van der Wall E, "Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer", Histopathology, pp. 46:31-6, 2005. DOI |
14 | Pignattelli M, Ansari TW, Gunter P, "Loss of membranous E-cadherin expression in pancreatic cancer correlation with lymph node metastasis, high grade, and advanced stage", J Pathol, pp .174:243-48, 1994. DOI |
15 | Norrby K, "Angiogenesis: new aspects relating to its initiation and control", APMIS, pp. 105:417-37, 1997. DOI |
16 | Tokunga T, Oshika Y, Abe Y, Ozeki Y, Sadshiro S, Kijima H, et al, "Vascular endothelial growth factor mRNA isoform expression pattern is correlate with liver metastases and poor prognosis in colon cancer", Br J Cancer, pp. 77:998-1002, 1998. DOI |
17 | Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, et al, "Vascular permeability factor, an endothelial cell mitogen related to PDG", Science, pp.246:1309-12, 1989. DOI |
![]() |